Murine Vs. Human Osteoblast Responses to Coagulation and Inflammatory Factors: Reconsidering the Use of Animal Models in Hemophilia a Research

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2025 Jan 8

PMID 39767573

Authors

Aline Bernar

Monika Bauer

Michael Schirmer

Werner Streif

Jennifer Gebetsberger

Affiliations

Soon will be listed here.

Abstract

: Hemophilia A is associated with frequent bleeding episodes, joint damage, and reduced bone mineral density (BMD). The role of coagulation factors and inflammatory cytokines on bone metabolism, particularly on osteoblast function, is of increasing interest. However, significant inter-species differences in bone remodeling raise concerns about the translatability of findings from murine models to human systems. This study aims to investigate the effects of human coagulation factors and cytokines on bone formation, focusing on inter-species differences in the cell viability and mineralization of murine and human osteoblasts. : Murine MC3T3-E1 and human SaOs-2 osteoblasts were cultured in osteoblast differentiation medium supplemented with various coagulation factors (FVIII, vWF, vWF-FVIII, FIX, FX, thrombin, and FVIII-thrombin) or cytokines (IL-6, TNF-α). Cell viability was assessed at both two-week and three-week time points using the CCK-8 assay, and mineralization was evaluated via Alizarin red S staining. Coagulation factors significantly enhanced cell viability in human osteoblasts but had no effects on the murine counterpart. FX inhibited mineralization in human cells, while murine cells showed no significant changes. TNF-α stimulated mineralization in murine osteoblasts but inhibited it in human cells, highlighting species-specific responses to inflammatory cytokines. Similar trends in response patterns were observed at two and three weeks, with greater consistency at the later time point. : These findings reveal critical inter-species differences in osteoblast responses to coagulation factors and cytokines, raising questions about the validity of using murine models to study human bone metabolism. Future research must account for these differences to ensure that preclinical models accurately reflect human pathophysiology, particularly in the context of hemophilia A.

References

Cai L, Lv Y, Yan Q, Guo W . Cytokines: The links between bone and the immune system. Injury. 2023; 55(2):111203. DOI: 10.1016/j.injury.2023.111203. View

Franchini M, Mannucci P . Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012; 7:24. PMC: 3502605. DOI: 10.1186/1750-1172-7-24. View

Ueda O, Tateishi H, Higuchi Y, Fujii E, Kato A, Kawase Y . Novel genetically-humanized mouse model established to evaluate efficacy of therapeutic agents to human interleukin-6 receptor. Sci Rep. 2013; 3:1196. PMC: 3561642. DOI: 10.1038/srep01196. View

Wang T, He C . TNF-α and IL-6: The Link between Immune and Bone System. Curr Drug Targets. 2019; 21(3):213-227. DOI: 10.2174/1389450120666190821161259. View

Pagel C, Sivagurunathan S, Loh L, Tudor E, Pike R, Mackie E . Functional responses of bone cells to thrombin. Biol Chem. 2006; 387(8):1037-41. DOI: 10.1515/BC.2006.128. View

Taves S, Sun J, Livingston E, Chen X, Amiaud J, Brion R . Hemophilia A and B mice, but not VWFmice, display bone defects in congenital development and remodeling after injury. Sci Rep. 2019; 9(1):14428. PMC: 6783554. DOI: 10.1038/s41598-019-50787-9. View

Pagel C, de Niese M, Abraham L, Chinni C, Song S, Pike R . Inhibition of osteoblast apoptosis by thrombin. Bone. 2003; 33(4):733-43. DOI: 10.1016/s8756-3282(03)00209-6. View

Lau A, Sun J, Hannah W, Livingston E, Heymann D, Bateman T . Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement. Haemophilia. 2014; 20(5):716-22. PMC: 4396845. DOI: 10.1111/hae.12399. View

Gerstner G, Damiano M, Tom A, Worman C, Schultz W, Recht M . Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia. 2009; 15(2):559-65. DOI: 10.1111/j.1365-2516.2008.01963.x. View

10.

Liel M, Greenberg D, Recht M, Vanek C, Klein R, Taylor J . Decreased bone density and bone strength in a mouse model of severe factor VIII deficiency. Br J Haematol. 2012; 158(1):140-3. DOI: 10.1111/j.1365-2141.2012.09101.x. View

11.

Hammacher A, Ward L, Weinstock J, Treutlein H, Yasukawa K, Simpson R . Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Protein Sci. 1994; 3(12):2280-93. PMC: 2142761. DOI: 10.1002/pro.5560031213. View

12.

Florencio-Silva R, Sasso G, Sasso-Cerri E, Simoes M, Cerri P . Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int. 2015; 2015:421746. PMC: 4515490. DOI: 10.1155/2015/421746. View

13.

Okamoto K, Takayanagi H . Osteoimmunology. Cold Spring Harb Perspect Med. 2018; 9(1). PMC: 6314075. DOI: 10.1101/cshperspect.a031245. View

14.

Recht M, Liel M, Turner R, Klein R, Taylor J . The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. Haemophilia. 2013; 19(6):908-12. DOI: 10.1111/hae.12195. View

15.

Czekanska E, Stoddart M, Richards R, Hayes J . In search of an osteoblast cell model for in vitro research. Eur Cell Mater. 2012; 24:1-17. DOI: 10.22203/ecm.v024a01. View

16.

Yen C, Fan M, Yang Y, Chou S, Yu I, Lin S . Current animal models of hemophilia: the state of the art. Thromb J. 2016; 14(Suppl 1):22. PMC: 5056469. DOI: 10.1186/s12959-016-0106-0. View

17.

Sato N, Ichikawa J, Wako M, Ohba T, Saito M, Sato H . Thrombin induced by the extrinsic pathway and PAR-1 regulated inflammation at the site of fracture repair. Bone. 2015; 83:23-34. DOI: 10.1016/j.bone.2015.10.005. View

18.

Blair H, Schlesinger P, Huang C, Zaidi M . Calcium signalling and calcium transport in bone disease. Subcell Biochem. 2008; 45:539-62. PMC: 2970924. DOI: 10.1007/978-1-4020-6191-2_21. View

19.

Daubie V, De Decker R, Nicaise C, Pochet R . Osteosarcoma cell-calcium signaling through tissue factor-factor VIIa complex and factor Xa. FEBS Lett. 2007; 581(14):2611-5. DOI: 10.1016/j.febslet.2007.04.078. View

20.

Mohammed B, Monroe D, Gailani D . Mouse models of hemostasis. Platelets. 2020; 31(4):417-422. PMC: 7244364. DOI: 10.1080/09537104.2020.1719056. View